All News

gout,MTP,tophi

Starting Febuxostat During an Acute Gout Flare

d Jack Cush, MD

A randomized controlled trial in gout patients has shown that starting febuxostat during an acute gout flare was without ill-effects and did not prolong the gouty attack.

Read Article
drug,capsules,antibotic

Early Antibiotic Use Increases JIA Risk

d Jack Cush, MD

A population based Swedish study of birth records shows that antibiotic exposure in first three years of life to be associated with a future risk of juvenile idiopathic arthritis (JIA), although infections during fetal life or childhood did not increase risk of JIA.

Read Article
joint.tap_.septic.monarthritis.jpg

Post-Arthroscopic Increase in Septic Arthritis

d Jack Cush, MD

A longitudinal study from Iceland shows an increasing number of native joint infections (NJI), with iatrogenic, postarthroscopic infections being of particular concern.

Read Article
tylenol,acetaminophen,pills,tablets

Is Acetaminophen Potentially Hazardous in Pregnancy?

d Jack Cush, MD

A consensus report from a multinational group of 91 scientists, clinicians and public health professionals alarmed the medical world last week as they suggest the use of acetaminophen (paracetamol) during pregnancy may have hazardous developmental effects on the fetus.

Read Article
Biosimilar update: 31 FDA approved biosimilars, but only 60% made it to market. 2015 to 2019, drug spending grew 6.1%, biologic spending grew 14.6%; biologics are 43% of US drug spending. Most biologics at ~30% discount. https://t.co/4paYH8yVLQ

Links:

Dr. John Cush RheumNow ( View Tweet)

MMWR shows the safety of a 3rd (booster) dose of the mRNA vaccine to be same as the 2nd dose AEs. V-safe data on 3rd dose (n=12,591) showed local or systemic effects (79% or 74%) to be same as 2nd dose (78% or 76%) https://t.co/LcD0ARlWJ2

Links:

Dr. John Cush RheumNow ( View Tweet)

#RA patients had an an increased risk of mortality after CABG (HR 1.50; 1.28-1.77); and a higher risk of MI following CABG (HR 1.61; 1.28-2.04). A retrospective Finnish study comparing RA (n= 378) to nonRA patients (n = 7560) https://t.co/cGGsrLs1V2

Links:

Dr. John Cush RheumNow ( View Tweet)

Tymlos (abaloparatide), for the postmenopausal osteoporosis, has a label update on the MOA, now reads as: "Once-daily...abaloparatide stimulates new bone formation on trabecular & cortical bone surfaces by stimulation of osteoblastic activity." https://t.co/AC9JvtmIdZ

Links:

Dr. John Cush RheumNow ( View Tweet)

Case controlled study suggests that intraarticular steroid injections is associated with increased (HR 8.56; 3.29-22.3) risk of rapidly destructive hip disease (RDHD); at a rate of 5.4% (5.1 mos post injx) w/ JSN, osteolysis, fem head collapse https://t.co/grX5bO4495

Links:

Dr. John Cush RheumNow ( View Tweet)

10 Signs You'd Make a Great Pathologist #PathTwitter #MedTwitter 1. You've been told that you "ask too many questions" at some point in your life.

Becca Brass, MD BeccaBrass ( View Tweet)

108 pts with autoimmune cytopenias (TTP, ITP, AIHA, etc) were given COVID vaccination showing low rate of post-vax flares. Signif HEME decreases in 7.4% of AIHA & ITP; mild decrease in 10% AIHA and 20% ITP, w/ no Rx change https://t.co/OaHILar57z

Links:

Dr. John Cush RheumNow ( View Tweet)

Variance in Uric acid? 85 pts without gout & serial SUA measured. 72/85 had nl SUA, but 21% later had high SUA x1. If SUA < 6, much less like to have future hyperuricemia (7% vs 39%, p = 0.0037). 13 w/ high SUA, half later had nl SUA. https://t.co/w05ll3OMbJ

Links:

Dr. John Cush RheumNow ( View Tweet)

Global SECURE-IBD trial on IBD drugs and COVID shows that severe COVID-19 outcomes were not associated with the use of biologics and mesalamine/sulfasalazine, AZA, 6MP, MTX combo Rx or biologics (TNFi, IL-12/23, IL-23, integrin inhib) https://t.co/MO4i5ngKkr

Links:

Dr. John Cush RheumNow ( View Tweet)

Prospective study of 77 RA patients in remission --> vax w/ BNT162b2 (BioNTech-Pfizer) (w/ temp D/C of DMARDs per ACR) found a vaccine-related flare rate of 7/8% (6 pts) w/ 5/6 flares after 2nd dose (2.6 days), resolved w/in 2 wks https://t.co/YOL3YVArvG #RheumNow https://t.co/dxRWhu8CJX

Links:

Dr. John Cush RheumNow ( View Tweet)
Can I get the INFLUENZA and COVID Vaccines together? The CDC says: "YES...both vaccines can be given at the same visit, people should follow the recommended schedule for either vaccine.... ideally get a flu vaccine by the end of October." https://t.co/T49zm6Cxyc

Links:

Dr. John Cush RheumNow ( View Tweet)

Patients with rheumatoid arthritis (RA) who had a history of cancer did NOT have an increased risk of new or recurrent cancers if treated with biologic therapies, a meta-analysis found. #RheumNow https://t.co/jM9oiRzXUk https://t.co/XYnaalEfe2

Links:

Dr. John Cush RheumNow ( View Tweet)
NEJM Image Challenge: A patient presented with painful and erythematous plaques on his hands and elbows. Lab examinations showed leukocytosis and thrombocytopenia. What is the diagnosis? https://t.co/kQrNuVmVXg https://t.co/4JGeExCcP7

Links:

NEJM NEJM ( View Tweet)
Aortitis: Let’s review the differential for #aortitis including Non-Infectious and Infectious Causes! @febrilepodcast x @RheumOnePagers | created by @MithuRheum @swinndong #IDTwitter #RheumTwitter #FOAMed https://t.co/pR0iTls4PK
Rheum OnePagers RheumOnePagers ( View Tweet)
New study on #COVID19Vaccine in autoimmune cytopenias 🩸7.4% had clinically significant ⬇️ in counts 🩸 All successfully managed w/steroids & transfusion 🩸 Mild ⬇️ in 10% AIHA and 20% ITP ⭐️Vaccination safe with close monitoring⭐️ https://t.co/qGZe6LiPKz

Links:

AmericanJournalofHematology AjHematology ( View Tweet)

Pooled analysis of the DISCOVER-1 and DISCOVER-2 trials have shown that guselkumab, an IL-23 inhibitor, was effective and safe in psoriatic arthritis (PsA) patients with axial involvement and imaging-confirmed sacroiliitis. #RheumNow https://t.co/yLCxyC1oLr https://t.co/Uloqx2phlh

Links:

Dr. John Cush RheumNow ( View Tweet)
×